Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

Се регрутира

Возраст од 45 до 70 · Сите полови · Ажурирано 2.9.2026 · NCT05080673

Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

University of Rochester Medical Center, Rochester

Се регрутираФаза 2

Возраст од 18 до 100 · Сите полови · Ажурирано 2.9.2026 · NCT07292298

A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.

Weill Cornell Medical College, New York
Brooklyn Methodist Hospital - NewYork Presbyterian, New York
New York Presbyterian Hospital - Queens, New York

Се регрутираФаза 2

Возраст од 18 до 90 · Сите полови · Ажурирано 29.7.2026 · NCT05024097

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
и уште 4

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 14.7.2026 · NCT06205485

Integrated Cancer Repository for Cancer Research

C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
Faxton St. Luke's Healthcare, Mohawk Valley, Utica

Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери

Возраст од 19 до 110 · Сите полови · Ажурирано 29.6.2026 · NCT02012699

The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer

New York Presbyterian Brooklyn Methodist Hospital, Brooklyn
Weill Cornell Medical College, New York
New York Presbyterian Hospital - Queens, New York

Се регрутира

Возраст од 18 до 90 · Сите полови · Ажурирано 15.6.2026 · NCT05943210

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

NYU Langone Medical Center, New York

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 12.6.2026 · NCT06051695

A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
и уште 1

Се регрутира

Возраст 18 и постари · Сите полови · Ажурирано 2.6.2026 · NCT06637462

Brodalumab in the Treatment of Immune-Related Adverse Events

Columbia University Irving Medical Center, New York

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 13.5.2026 · NCT06673329

A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

Memorial Sloan Kettering Cancer Center at Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
и уште 1

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 12.5.2026 · NCT05672524

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

Memorial Sloan Kettering Cancer Center, New York

Се регрутираНабљудувачка студија

Возраст 18 и постари · Сите полови · Ажурирано 12.3.2026 · NCT04668872

Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)

Columbia University Irving Medical Center, New York

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 25.2.2026 · NCT07433673

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Buffalo
Massive Bio SYNERGY-AI site, Hempstead
Massive Bio SYNERGY-AI site, Manhasset
и уште 2

Се регрутираНабљудувачка студија

Сите возрасти · Сите полови · Ажурирано 28.10.2025 · NCT03452774

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

NYU Langone Health, New York

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 9.9.2025 · NCT06682793

Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population

Bassett Healthcare Network, Cooperstown

Се регрутираНабљудувачка студија

Возраст 18 и постари · Сите полови · Ажурирано 7.3.2023 · NCT04245683

Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.